NCT00554827 2020-01-03
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
Phase 1 Completed
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Endocyte
Endocyte
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Eli Lilly and Company